71 - HIV Update for the General ID Practitioner

Friday, October 1, 2021

10:00 AM - 11:15 AM EDT

Moderator(s)

Harry Lampiris, MD

Professor
University of California, San Francisco
San Francisco, CA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

Jehan Budak, MD

Assistant Professor
University of Washington, WA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mamta Jain, MD, MPH

Professor
UT Southwestern Medical Center
Dallas, Texas, United States

Gilead Sciences Inc. (Individual(s) Involved: Self): Research Grant or Support, Scientific Research Study Investigator; GlaxoSmithKline (Individual(s) Involved: Self): Scientific Research Study Investigator; Merck (Individual(s) Involved: Self): Scientific Research Study Investigator; Vasgene (Individual(s) Involved: Self): Scientific Research Study Investigator
Kimberly Workowski, MD

Professor of Medicine, Division of Infectious Diseases
Emory University
Atlanta, GA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:

Harry W. Lampiris, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Jehan Budak, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Mamta K. Jain, MD, MPH: Gilead Sciences Inc. (Individual(s) Involved: Self): Research Grant or Support, Scientific Research Study Investigator; GlaxoSmithKline (Individual(s) Involved: Self): Scientific Research Study Investigator; Merck (Individual(s) Involved: Self): Scientific Research Study Investigator; Vasgene (Individual(s) Involved: Self): Scientific Research Study Investigator

Kimberly Workowski, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe changes in HIVMA, DHHS Guidelines as they pertain to primary care of patients with HIV
list changes in 2021 CDC STD Guidelines as they pertain to adult patients with HIV infection
describe novel agents recently approved to treat HIV Infection

Presentations:

Antiretroviral Treatment Update
Speaker: Jehan Budak, MD – University of Washington
HIV Primary Care Update
Speaker: Mamta K. Jain, MD, MPH – UT Southwestern Medical Center
Management of STIs
Speaker: Kimberly Workowski, MD – Emory University